Chapter/Section Purchase

1 Study Coverage
1.1 Oncolytic Virus Immunotherapy Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Oncolytic Virus Immunotherapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Oncolytic Virus Immunotherapy Market Size for the Year 2017-2028
1.2.2 Global Oncolytic Virus Immunotherapy Market Size for the Year 2017-2028
1.3 Oncolytic Virus Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Oncolytic Virus Immunotherapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Oncolytic Virus Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Oncolytic Virus Immunotherapy Market Dynamics
1.4.1 Oncolytic Virus Immunotherapy Industry Trends
1.4.2 Oncolytic Virus Immunotherapy Market Drivers
1.4.3 Oncolytic Virus Immunotherapy Market Challenges
1.4.4 Oncolytic Virus Immunotherapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Oncolytic Virus Immunotherapy by Type
2.1 Oncolytic Virus Immunotherapy Market Segment by Type
2.1.1 Engineering Oncolytic Viruses
2.1.2 Wild-Type Oncolytic Viruses
2.2 Global Oncolytic Virus Immunotherapy Market Size by Type (2017, 2022 & 2028)
2.3 Global Oncolytic Virus Immunotherapy Market Size by Type (2017-2028)
2.4 United States Oncolytic Virus Immunotherapy Market Size by Type (2017, 2022 & 2028)
2.5 United States Oncolytic Virus Immunotherapy Market Size by Type (2017-2028)
3 Oncolytic Virus Immunotherapy by Application
3.1 Oncolytic Virus Immunotherapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Oncolytic Virus Immunotherapy Market Size by Application (2017, 2022 & 2028)
3.3 Global Oncolytic Virus Immunotherapy Market Size by Application (2017-2028)
3.4 United States Oncolytic Virus Immunotherapy Market Size by Application (2017, 2022 & 2028)
3.5 United States Oncolytic Virus Immunotherapy Market Size by Application (2017-2028)
4 Global Oncolytic Virus Immunotherapy Competitor Landscape by Company
4.1 Global Oncolytic Virus Immunotherapy Market Size by Company
4.1.1 Top Global Oncolytic Virus Immunotherapy Companies Ranked by Revenue (2021)
4.1.2 Global Oncolytic Virus Immunotherapy Revenue by Player (2017-2022)
4.2 Global Oncolytic Virus Immunotherapy Concentration Ratio (CR)
4.2.1 Oncolytic Virus Immunotherapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Oncolytic Virus Immunotherapy in 2021
4.2.3 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Oncolytic Virus Immunotherapy Headquarters, Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Oncolytic Virus Immunotherapy Headquarters and Area Served
4.3.2 Global Oncolytic Virus Immunotherapy Companies Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Oncolytic Virus Immunotherapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Oncolytic Virus Immunotherapy Market Size by Company
4.5.1 Top Oncolytic Virus Immunotherapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Oncolytic Virus Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Oncolytic Virus Immunotherapy Market Size by Region
5.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Oncolytic Virus Immunotherapy Market Size by Region (2017-2028)
5.2.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2017-2022
5.2.2 Global Oncolytic Virus Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
6.1.2 North America Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
6.3.2 Europe Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
6.4.2 Latin America Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Oncolytic Virus Immunotherapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Oncolytic Virus Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Details
7.1.2 Merck Business Overview
7.1.3 Merck Oncolytic Virus Immunotherapy Introduction
7.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.1.5 Merck Recent Development
7.2 Amgen
7.2.1 Amgen Company Details
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
7.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.2.5 Amgen Recent Development
7.3 TILT Biotherapeutics
7.3.1 TILT Biotherapeutics Company Details
7.3.2 TILT Biotherapeutics Business Overview
7.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
7.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.3.5 TILT Biotherapeutics Recent Development
7.4 Oncorus
7.4.1 Oncorus Company Details
7.4.2 Oncorus Business Overview
7.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
7.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.4.5 Oncorus Recent Development
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Company Details
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
7.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.5.5 Sorrento Therapeutics Recent Development
7.6 Shanghai Sunway Biotech
7.6.1 Shanghai Sunway Biotech Company Details
7.6.2 Shanghai Sunway Biotech Business Overview
7.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
7.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
7.6.5 Shanghai Sunway Biotech Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer